Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy

被引：0
|
作者：
Shimpei Tsudaka
Hiromasa Yamamoto
Hiroki Sato
Kuniaki Katsui
Ken Suzawa
Kazuhiko Shien
Kentaroh Miyoshi
Shinji Otani
Mikio Okazaki
Seiichiro Sugimoto
Masaomi Yamane
Katsuyuki Kiura
Susumu Kanazawa
Shinichi Toyooka
机构：
[1] Okayama University Graduate School of Medicine,Departments of General Thoracic Surgery and Breast and Endocrinological Surgery
[2] Dentistry and Pharmaceutical Sciences,Departments of Proton Beam Therapy
[3] Okayama University Graduate School of Medicine,Departments of Hematology, Oncology and Respiratory Medicine
[4] Dentistry and Pharmaceutical Sciences,Departments of Radiology
[5] Okayama University Graduate School of Medicine,Departments of Thoracic Surgery
[6] Dentistry and Pharmaceutical Sciences,Departments of Radiology
[7] Okayama University Graduate School of Medicine,Departments of Allergy and Respiratory Medicine
[8] Dentistry and Pharmaceutical Sciences,Organ Transplant Center
[9] Okayama University Hospital,undefined
[10] Okayama University Hospital,undefined
[11] Okayama University Hospital,undefined
[12] Okayama University Hospital,undefined
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4880 / 4890
页数：10
相关论文
共 50 条
  • [21] Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy
    Guo, Dong
    Li, Minghuan
    Chen, Dawei
    Jing, Wang
    Zhu, Hui
    Fu, Lei
    Kong, Li
    Yue, Jinbo
    Yu, Jinming
    [J]. FUTURE ONCOLOGY, 2019, 15 (06) : 625 - 635
  • [22] Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
    Shen, Jinwen
    Zhu, Yuan
    Wu, Wei
    Zhang, Lingnan
    Ju, Haixing
    Fan, Yongtian
    Zhu, Yuping
    Luo, Jialin
    Liu, Peng
    Zhou, Ning
    Lu, Ke
    Zhang, Na
    Li, Dechuan
    Liu, Luying
    [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 315 - 324
  • [23] Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy
    Zattarin, Emma
    Manglaviti, Sara
    Apollonio, Giulia
    Beninato, Teresa
    Mazzeo, Laura
    Massa, Giacomo
    Bottiglieri, Achille
    Galli, Edoardogregorio
    De Toma, Alessandro
    Occhipinti, Mario
    Brambilla, Marta
    Ferrara, Roberto
    Ganzinelli, Monica
    Proto, Claudia
    Garassino, Marina Chiara
    de Braud, Filippo
    Lo Russo, Giuseppe
    Prelaj, Arsela
    [J]. FUTURE ONCOLOGY, 2022, 18 (23) : 2593 - 2604
  • [24] Pretreatment Neutrophil-to-Lymphocyte Ratio and Smoking History as Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Osimertinib
    Park, Ji Young
    Jang, Seung Hun
    Lee, Chang Youl
    Kim, Taehee
    Chung, Soo Jie
    Lee, Ye Jin
    Kim, Hwan Il
    Kim, Joo-Hee
    Park, Sunghoon
    Hwang, Yong Il
    Jung, Ki-Suck
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2022, 85 (02) : 155 - 164
  • [25] Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Lim, Jeong Uk
    Kang, Hye Seon
    Yeo, Chang Dong
    Kim, Ju Sang
    Park, Chan Kwon
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 2824 - 2832
  • [26] How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer
    H Kunitoh
    K Suzuki
    [J]. British Journal of Cancer, 2007, 96 : 1498 - 1503
  • [27] Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors
    Amaral, S. R.
    Casal Moura, M.
    Carvalho, J.
    Chaves, A.
    Jesus, E.
    Sousa, G.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [28] How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer
    Kunitoh, H.
    Suzuki, K.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (10) : 1498 - 1503
  • [29] Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer
    Alshamsan, Bader
    Elshenawy, Mahmoud A.
    Aseafan, Mohamed
    Fahmy, Nermin
    Badran, Ahmed
    Elhassan, Tusneem
    Alsayed, Adher
    Suleman, Kausar
    Al-Tweigeri, Taher
    [J]. ONCOLOGY LETTERS, 2024, 28 (03)
  • [30] Trimodality therapy for locally advanced non-small cell lung cancer
    Lackner, R. P.
    Ganti, A.
    Zhen, W.
    Copur, M. S.
    Vaziri, I. A.
    Bolton, M.
    Hlavaty, T.
    Trujillo, K. P.
    Kessinger, M. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345